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Abstract: 
The organisms that colonize the human body over a lifetime are diverse, extensive and 
gargantuan.  A fair proportion of the microbiota that constitutes this human microbiome 
live within our oral cavities mostly as harmonious associates causing only sporadic disease. 
An important core constituent of the microbiome is the mycobiome, representing various 
fungal genera.  Up until recently, only a few species of fungi, mainly Candida species, were 
thought to constitute the human oral mycobiome. The reasons for this are manifold, 
although the uncultivable nature of many fungi in conventional laboratory media, and their 
complex genetic composition seem to be the major factors which eluded their detection 
over the years. Nevertheless, recent advances in computing and high throughput 
sequencing such as next generation sequencing (NGS) platforms have provided us a 
panoramic view of a totally new world of fungi that are human oral co-habitués. Their 
diversity is perplexing, and functionality yet to be deciphered. Here we provide a glimpse of 
what is currently known of the oral mycobiome, in health and disease, with some future 
perspectives. 
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Introduction 
The human body, like all other complex multicellular eukaryotes, is inhabited by a 
bewildering array of microbes. Bacterial constituents make up over 99 % of total microbial 
counts, hence termed the core microbiome, whilst the remaining, less abundant and more 
diverse flora forms a ‘rare biosphere’ (Dethlefsen, Huse, Sogin, & Relman, 2008; Sogin et al., 
2006). A significant proportion of the rare biosphere, in turn is represented by fungi - the 
mycobiome. Despite the low abundance, the impact of the mycobiome on human health 
and disease is wide-ranging. For instance, it is estimated that over 600 out of 5.1 million 
species of fungi comprising the rare biosphere cause human disease (Blackwell, 2011; 
Hawksworth & Lucking, 2017) ranging from mild superficial disease to deep seated, life-
threatening, systemic infections (Brown, Denning, & Levitz, 2012; Huffnagle & Noverr, 
2013). 
Although a vast multitude of bacteria have been recognized, classified and categorized as 
can be seen in the Human Microbiome Project (HMP), critical components of the rare 
biosphere including the mycobiome, virome (syn. virobiome) and parasitome have received 
less attention. Despite the ever-rising incidence of fungal infections, particularly due to the 
burgeoning immunocompromised populations worldwide, the diversity and the 
functionality of resident fungi in the human body is therefore an under-researched area.  
Particularly relevant to the current review, the fungal component of the oral microbiome, 
the ‘oral mycobiome’ has also received scant attention. The reasons for this are manifold, 
the uncultivable nature of many fungi in conventional laboratory media and their complex 
genetic composition as eukaryotes seem to be the key reasons that may have eluded their 
detection over the years. Additionally, the growth of the oral mycobiome constituents, 
thought to comprise less than 0.1% of the oral microbiome based on conventional colony 
forming unit (CFU) analysis (Baker, Bor, Agnello, Shi, & He, 2017), appears to have been 
overshadowed by the predominant bacteria in traditional laboratory cultures of oral 
samples. Other reasons include, difficulties in nomenclature of fungi and annotating fungal 
databases and the historical redundancies and errors associated with fungal nomenclature. 
What follows is a review of the data emanating from the use of newer technologies, such as 
NGS platforms that throw light on the composition and the physiology of the oral 
mycobiome. After discussing the latter attributes of the mycobiome we review the impact 
of the extant new information on our understanding of the oral ecosystem in various 
diseased states such as endodontic infections, periodontal disease, and oral squamous cell 
carcinomas.    
 
Newer microbial detection technologies and the oral mycobiome 
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Characterization of fungal communities including the oral mycobiome has evolved, but 
relatively slowly, compared with the oral bacteriome. Once genetic material-based 
detection technologies were introduced in early 1990s, the shortcomings of traditional 
culture- based clinical laboratory techniques and identification of human fungal pathogens 
using selective media and, biochemical assays were evident. Gene-based identification of 
fungi has led to the documentation of unique sequences in fungal ribosomes. The genetic 
loci enclosing the 18S, 5.8S, and 28S rRNA genes, internal transcribed spacer (ITS) regions 
between the 18S and 28S rRNA genes (ITS1 and ITS2), and the non-functional RNA coding 
DNA that transcribe during rRNA synthesis, have been principally targeted in recent culture 
independent, gene based fungal identification techniques (Hershkovitz & Lewis, 1996; Hillis 
& Dixon, 1991; Nilsson, Kristiansson, Ryberg, Hallenberg, & Larsson, 2008).  
The most recent, state of the art next generation sequencing (NGS) technology also uses 
targets similar to ITS regions, and clone libraries derived from the components of rRNA (16S, 
5.8S, and 28S rRNA genes). Unlike the more advanced and extensive bacterial databases, 
the fungal ribosomal database is still immature, although, recent inclusions tend to show 
the perplexing diversity of the human mycobiome, including the oral mycobiome. (Charlson 
et al., 2012; Delhaes et al., 2012; Gardes & Bruns, 1993; Ghannoum et al., 2010; Lindsley, 
Hurst, Iqbal, & Morrison, 2001). As members of the rare biosphere, the physiology, lifestyle 
and host pathogen interactions of a vast proportion of these recently identified uncultivable 
fungi are yet to be fully unravelled.  
As for the oral mycobiome, there was a general consensus until recently, both by the 
scientific and the clinical community, that Candida species are the predominant 
opportunistic oral pathogens of clinical significance (Samaranayake, 2018). This, despite that 
fact that lesser known fungi other than Candida species were sporadically and infrequently 
cultured from oral samples, particularly from medically compromised individuals. Some of 
these infrequently isolated species included Saccharomyces cerevisiae, Penicillium, 
Aspergillus, Geotrichum, Hemispora, Scopulariopsis, and Hormodendrum species (Jabra-Rizk 
et al., 2001; Salonen et al., 2000; Schuster, 1999). However, newer mycobiome studies using 
NGS have recently revealed the existence of Malassezia species in a majority of oral 
samples, an organism that has rarely, if ever, isolated from the mouth. The role of 
Malassezia in oral health and disease is yet to be defined. 
One of the pioneering and seminal studies that used a Multitag Pyrosequencing approach 
was conducted by Gahnnoum et al., (2010). Pyrosequencing analysis was the predecessor to 
the NGS platforms that are currently in use. The latter group for the first time described the 
‘basal oral mycobiome’ of healthy individuals. They reported 74 culturable and 11 non-
culturable fungal genera and a total of 101 different fungal species in the oral samples from 
20 healthy individuals. Not unexpectedly, the most common genera isolated belonged to 
Candida species (obtained from 75% of all study subjects) followed by Cladosporium (65%). 
One half of the cohort carried Aureobasidium and Saccharomycetales, and notable 
quantities of Aspergillus (35%), Fusarium (30%), and Cryptococcus (20%) were also 
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identified.  C. albicans were isolated in 40% of the subjects while 15% carried Candida 
parapsilosis and Candida tropicalis and 5% carried Candida khmerensis and Candida 
metapsilosis (Ghannoum et al., 2010). The relative distribution of various Candida species 
was similar to those reported in previous studies using conventional technology 
(Samaranayake & MacFarlane, 1990). 
Following this study, Dupuy et al., evaluated the ‘human core mycobiome’ (Dupuy et al., 
2014) using an improved approach of pyrosequencing in order to i) overcome process-
induced sequencing errors, ii) to accurately assign fungal taxonomy and iii) to develop a 
proper binary naming and phylogenetic classification. This was the first study to reveal the 
presence of Malassezia species, previously known to be a skin commensal and an 
opportunistic pathogen, as a predominant commensal of saliva. So, how did oral Malassezia 
species evade detection for virtually decades?  Some reasons could be i) the necessity for 
additional lipids in culture media for their growth due to their incomplete fatty acid 
synthetic potency, ii) incubation over prolonged periods required to elicit growth in 
conventional mycological media and, iii) their extreme sensitivity and inability to withstand 
harsh protocols used in early molecular detection methods (Findley et al., 2013; Imabayashi 
et al., 2016; Monteiro-da-Silva, Araujo, & Sampaio-Maia, 2014; Shelburne et al., 2015; Wu et 
al., 2015). Hence, it is not surprising that the identity of the organism by culture-based 
methods eluded oral mycologists thus far. 
The two pioneering studies on the oral mycobiome by Ghannoum et al., and Dupuy et al., 
stated above, entailed the use of comparable methodology but the results were somewhat 
dissimilar. Out of 13 fungi recognized by Ghannoum et al., (i.e.  Alternaria, Aspergilllus, 
Aureobasidium, Candida, Cladosporium, Cryptococcus, Dothioraceae, Eurotium, Fusarium, 
Glomus, Saccharomyces, Saccharomycetales, and Teratosphaeria), Dupuy and colleagues did 
not detect Glomus, Teratosphaeria, Saccharomycetales and Dothioraceae in their samples. 
In contrast, they observed five new genera of fungi; Malassezia, Irpex, Cytospora/Valsa, 
Lenzites/Trametes, and Sporobolomyces/Sporidiobolus in saliva samples of all six individual 
participants (Dupuy et al., 2014).  
Clearly, to the surprise of the oral microbiologists, the foregoing work, essentially focusing 
on the healthy oral mycobiome revealed an array of exotic, pathogenic fungi within the oral 
mycobiome. These studies were indeed the forerunners for those investigating the 
mycobiome of a variety of other oral diseases ranging from periodontal disease to oral 
carcinomas. 
 
Technical Challenges in oral mycobiome analysis 
It is clear that the culture independent microbial identification techniques have expanded 
our understanding of the human mycobiome. However, like any other microbial 
identification systems, novel molecular approaches also carry associated challenges. With 
the emergence of the `big data` on the oral mycobiome, there is a concomitant and an 
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urgent need for a well-curated oral mycobiome database. Deposition of vague and 
erroneously annotated entries, redundant taxa and, sequences created as a consequence of 
primer artefacts in publicly available repositories such as GenBank are likely to generate 
unreliable outcomes during taxonomic identifications of unknown oral mycobiota (Dupuy et 
al., 2014; Nilsson et al., 2006).  
Recently, efforts have been made to construct a niche-specific reference set to avoid 
inaccuracies generated using hitherto existing databases such as UNITE and Fungal ITS 
RefSeq Targeted Loci Project (Abarenkov et al., 2010; Findley et al., 2013; Irinyi et al., 2015; 
Tang, Iliev, Brown, Underhill, & Funari, 2015). Nevertheless, compounding fungal 
nomenclature, particularly fungal species possessing multiple names based on their 
morphological (sexual vs asexual), geographical and historical characteristics, is likely to 
complicate high throughput identification of mycobiota from the human oral mycobiome 
(Hibbett & Taylor, 2013; Quaedvlieg et al., 2014; Taylor, 2011). 
Further, due to the wide variations in the fungal ITS amplicon lengths (~200-~600 base 
pairs), ITS based fungal surveys must be carried out with extreme care. This is critical to 
prevent erroneous bidirectional sequencing due to overlaps between forward and reverse 
reads and, to prevent potential bias when selecting the amplification length when 
calculating the quantity (Tang et al., 2015). In addition, ITS regions exhibit remarkably 
greater sequence variations within the same species making it difficult to generate similarity 
thresholds to define open taxonomic units (OTU) at a species-specific level.   
Also, the interspecies variations of ITS copy number among fungi (few to ~ 250) complicate 
the quantitative estimation of the fungal load using universal primers (Liu et al., 2012).  
Species specific primers would only be useful when the copy number of the target 
sequences in a particular species is hitherto known as some important species in the oral 
mycobiome possess variable copy numbers among the strains, e.g. C. albicans (56-222 
copies) and A. fumigatus (38-91 copies) (Herrera, Vallor, Gelfond, Patterson, & Wickes, 
2009; Rustchenko, Curran, & Sherman, 1993). Due to such variations in ITS sequences, 
various other additional genes have been used to discriminate among species (multigene 
approach) (Hibbett & Taylor, 2013).  
These challenges further point to the importance of robust novel approaches to precisely 
identify fungi at a species-specific level. Nevertheless, further improvements and 
refinements and fungal identification technology through advanced platforms, and 
resolution of taxonomic issues inherently extant in fungal nomenclature should help precise 
delineation of the oral mycobiome in the not too distant future.  
 
Oral mycobiome and oral physiology 
The fluctuations of the functionality and the dynamics of the human microbiome in 
response to physiological vagaries such as age and diet are well known. Similar to their 
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bacterial counterpart, the mycobiome also exhibits changes in response to physiological 
vicissitudes of the human body. For instance, fungal ITS1 sequencing of saliva samples 
collected from community dwelling elderly (77-99 years of age) has revealed a significant 
positive association of oral mycobiota with increasing age, number of missing teeth, denture 
wearing, and low salivary flow rates (Ikebe, Morii, Matsuda, Hata, & Nokubi, 2006). 
Although the artificial retention areas offered by dentures may be a major reason for this 
observation, it is clear that other factors such as reduced salivary flow and the quality of the 
mucosa associated with advancing age may have played a contributory role in the changing 
landscape of the oral mycobiome (Samaranayake, 2018). In another previous investigation, 
despite the differences in primers used, community dwelling elderly possessed lower total 
fungal load in their oral mycobiome compared to those institutionalized (Li et al., 2012). The 
reasons for this are unclear, although communal sharing of utensils and poor hygiene could 
be attributable to these observations. Uncultivable oral mycobiota in advancing age has not 
been studied and is warranted to fill this glaring gap in knowledge. 
It appears that oral Candida species significantly vary especially in elderly from diverse 
geographical and ethnic backgrounds, and non-albicans species are estimated to be 
predominant in Asian populations (Falagas, Roussos, & Vardakas, 2010; Kraneveld et al., 
2012; Samaranayake, 2009). For instance, one study indicates that the oral carriage of 
Candida krusei in leprosy patients in Thailand is higher than C. albicans (36% vs 10% control) 
- the most common oral yeast isolate in humans (Reichart, Samaranayake, & Philipsen, 
2000).   Samaranayake et al., noted on review of 44 publications in the literature for which 
statistics on rates of human carriage of C. krusei are available, the highest carriage rates to 
be 6.1% for the oral cavity, 10.3% for the gastrointestinal tract, and 12.5% for the vagina 
either in health or in disease (Samaranayake & Samaranayake, 1994). They hypothesized 
that the exceptionally high prevalence of C. krusei in the leprosy cohort, could be attributed 
to the institutionalization and the shared dietary regimens possibly originating from a 
common outlet. NGS studies of population groups in diverse geographic locales and 
ethnicities should be of extreme interest to obtain a clearer picture of their oral mycobiome. 
In comparison to the elderly, the carriage of Candida in the oral cavities of infants at birth is 
lower and colonization rates rise with age reaching adult carriage rates in the first year of 
life (Kleinegger, Lockhart, Vargas, & Soll, 1996; Russell & Lay, 1973; Ward, Knights, & Gale, 
2017).  In another recent study, Zakaria et al., noted that the oral cavities of those with 
lower BMI (body mass index) were more frequently colonized with Candida dubliniensis and 
Candida glabrata while those with lower salivary flow rates were colonized by C. albicans 
(Zakaria et al., 2017). Nonetheless, new studies using novel, culture independent analyses, 
such as NGS technology are needed to re-evaluate the fungal diversity in human mouth 
under changing physiological and chronological conditions as historical data are likely to be 
biased towards the yeasts that flourished in conventional laboratory culture. 
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Saliva and the mycobiome  
There are two recent studies in the literature investigating the salivary mycobiome. The first 
is the afore mentioned seminal study of Ghannoum et al., (2010) which evaluated oral rinse 
samples that could be considered as surrogate salivary samples, and the second is that of 
Monteiro-da-Silva et al., (2014) which evaluated salivary samples using a longitudinal 
approach. 
Ghannoum et al., noted in 20 healthy adults a basal mycobiome of 74 culturable and 11 
non-culturable fungal genera.  Among these genera, 39 were present in only one person, 16   
were present in two participants, and five were present in three individuals, while 15 genera 
(including non-culturable organisms) were present in ≥4 (20%) participants. Candida species 
were the most frequent followed by Cladosporium (65%), Aureobasidium, 
Saccharomycetales (50% for both), Aspergillus (35%), Fusarium (30%), 
and Cryptococcus (20%) (Ghannoum et al., 2010).   
The second study of salivary samples collected over the period of 30 weeks revealed that, 
despite no intraindividual variations over time, the prevalence of moulds and yeasts, 100% 
and 92.5% of samples respectively, was significantly higher in the oral cavities (Monteiro-da-
Silva et al., 2014). The moulds were mainly Penicillium spp., Aspergillus spp., and 
Cladosporium spp. and yeasts were predominantly Candida spp. and Rhodotorula spp. 
(Monteiro-da-Silva et al., 2014). Interestingly. The latter three mould species together with 
Candida are known to be human pathogens, especially in compromised patient groups. 
Salivary mycobiome studies are still in its infancy. Yet to be explored areas include the 
natural history and the evolution of the mycobiota from birth to adulthood in healthy and 
diseased individuals. On the other hand, information on the mycobiota of a few diseased 
states of the oral cavity are emerging as discussed below.   
 
Mycobiome of periodontal disease   
Microbiology of periodontal diseases is complex. Although there is consensus as to a few 
key periodontopathogens (the so-called red complex bacteria or key stone pathogens) that 
are involved in periodontal diseases, further work is clearly necessary to demystify the 
pathogenesis of this disease. There have also been recent calls that fungi may play a role in 
periodontal diseases (Canabarro et al., 2013). The latter group noted several yeast species 
such as C. parapisilosis, Rhodotorula spp., C. dubliniensis and C. tropicalis in both healthy 
and periodontitis cohorts but only C. albicans was present in all the patients with yeast
positive periodontitis.  
There is one recent study by Peters et al., (2017) evaluating the mycobiome of periodontal 
patients. The latter workers studied patients with periodontal infections using fungal ITS1 
sequencing and noted no less than 150 fungal species belonging to at least five phyla 
including Ascomycota, Basidiomycota, Glomeromycota, Chytridiomycota, together with an 
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abundance of unclassified organisms (Peters, Wu, Hayes, & Ahn, 2017). Another intriguing 
finding was a predominance of phylum Ascomycota (86.5%) in both the healthy and the 
periodontally affected individuals. In line with previous findings, Candida and Aspergillus 
were isolated from all the samples (100% prevalence), and Penicillium (97%), Schizophyllum 
(93%), Rhodotorula (90%), and Gibberella (83%) too were frequent isolates. Not 
unexpectedly, there were a significant proportion of unidentified fungi as well. Interestingly, 
Peters et al., could not find a significant difference in the overall composition of the 
mycobiome between the periodontally affected and the healthy cohorts (Peters et al., 
2017), although there was a clear association between tooth loss and increased prevalence 
of Candida. Furthermore, isolation of 14 different open reading frames (OTUs) from patients 
with periodontitis suggested that rare Candida spp. may be associated with periodontal 
diseases, particularly in the subgingival sites that provide favourable habitats for yeasts 
(Canabarro et al., 2013). 
In vitro studies have shown that the keystone bacterial pathogens such as P. gingivalis and 
A. actinomycetemcomitans physically interact with Candida species. For instance, both non-
vital C. albicans and its cell wall components (mannoprotein-b-glucan complex) enhances P. 
gingivalis invasion of oral mucosal cells via unknown mechanisms (Tamai, Sugamata, & 
Kiyoura, 2011). In addition, A. actinomycetemcomitans also binds to C. albicans hyphae, and 
yet inhibits the fungal growth through quorum sensing signalling (Bachtiar et al., 2014). 
Sztukowska et al. (2018) have recently characterized the interactions between C. albicans 
and P. gingivalis and demonstrated that co-adhesion mediated by specific proteins results in 
major changes in gene expression by P. gingivalis, which could serve to increase their 
pathogenic potential. This implies that interdomain interactions can modulate oral diseases 
(Sztukowska et al., 2018). Considering the fact that the etiologic flora of periodontal disease 
is yet to be fully unravelled, these findings give credence to those who propose that the 
mycobiome is a key player in the initiation and progression of periodontal infections.  
 
Mycobiome of Endodontic infections   
Although there are many studies on the bacteriome of endodontic infections (Hong et al., 
2013; Tawfik, Azab, Ahmed, & Fayyad, 2018), there are scant data on its mycobiome 
evaluated by newer techniques uncovering the uncultivable flora. In a relatively recent 
study, Gomes et al., (Gomes, Fidel, Fidel, & de Moura Sarquis, 2010), isolated filamentous 
fungi from over one fourth of the root canals of teeth with pulp necrosis and identified 
Aspergillus spp. (ustus, granulosus, niger, sydowii) Emericella quadriluniata (sexual form of 
Aspergillus), Penicillium species (implicatum, micsynvisk, lividum and citrionigrum), Fusarium 
(moniliforme and melanochorum), Aureobasidium pullulans, Exophiala jeanselmei, Eurotium 
amstelodame and Cladosporium sphaerospermum. More recently, Persoon et al., noted 
(using sequenced data of ITS1 or ITS2 regions of ribosomal RNA) that Candida and 
Malassezia as the most frequently isolated fungi from endodontic samples collected from 
six infected canals (Persoon, Buijs, et al., 2017). Despite the small number of samples tested 
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and the low diversity of the fungi isolated, the commonest isolates were Candida, 
Cladosporium, Epicoccum, Malassezia, and Saccharomyces species. These findings are akin 
to those of the salivary mycobiome mentioned above (Dupuy et al., 2014; Ghannoum et al., 
2010) thus questioning the veracity and the integrity of their sample collection method.   
In a recent systematic review of 54 select studies on fungi in endodontic infections Persoon 
et al., (2017) concluded an overall 7.5%prevalence of fungi in root canal infections 
predominated by Candida species (Persoon, Crielaard, & Ozok, 2017). The vast majority of these 
were culture-based investigations. Taken together, the foregoing points to the fact that a 
rich mycobiota may exist and cause, endodontic infections and a comprehensive picture of 
the infected root canal mycobiome awaits discovery through the use of newer technology. 
 
Oral mycobiome in compromised patient populations 
There are two studies evaluating the mycobiota in compromised patients using newer 
technologies, particularly in HIV disease and in leukemic patients.  
Despite the wide use of ART (antiretroviral therapy), the incidence of oral candidiasis in HIV 
infected individuals is a relatively common finding (Patel et al., 2012; Thompson et al., 
2010). Oral candidiasis is considered as a harbinger of worsening CD4+ cell counts and 
transition of HIV infected status to AIDS (Samaranayake, 2018). Using a pyrosequencing 
approach, Mukharjee et al., compared the oral mycobiomes of HIV-infected individuals with 
a healthy cohort (Mukherjee et al., 2014).  Unlike the bacteriome of the participants, the 
oral mycobiome exhibited significant differences in composition between the two groups. 
HIV infected patients carried higher numbers of Candida (92%; most abundant), Epicoccum, 
and Alternaria while healthy individuals had an abundance of Candida (58%), Pichia, and 
Fusarium. While Candida and Penicillium were common in both groups, Candida occurred in 
higher frequencies in HIV patients. Interestingly, Pichia decreased in HIV infected individuals 
with a concomitant rise in Candida suggesting a potential antagonistic relationship between 
these fungi (Mukherjee et al., 2014). In contrast, Aas et al., noted only two fungal species, C. 
albicans and S. cerevisiae, in subgingival plaque in HIV-infected individuals (Aas et al., 2007). 
Smaller sample size and the differences in microbial isolation, detection and sequencing 
techniques may have led to these disparate results.  
There is a single study evaluating the interactions of a compromised host, genetic 
polymorphisms, and the mycobiome. Shelburne et al., in 2015 isolated Malassezia 
velutinosus DNA in oral samples form a leukemic patient with invasive mucormycosis and 
concluded that the host-microbiome-mycobiome triad is important in understanding the 
pathogenesis of disease complexes in compromised patients and their clinical outcomes 
(Shelburne et al., 2015). It is noteworthy here that host-mycobiome interactions either in 
the oral cavity or other regions of the human body are yet to be explored, and the current 
data are tentative and sparse at best. 
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 Oral mycobiome in oral candidiasis 
In a very early seminal study Samaranayake et al., (1987) have shown, using differential 
media such a Pagano-Levin agar, which was the precursor of the commercially available 
Chrome agar, the phenomenon of multi-species oral carriage of Candida in a population of 
patients presenting in a British dental hospital.  They noted that some 15% of the oral 
Candida infections in their cohort were polymicrobial in nature, and caused by mixed 
Candida species (Samaranayake, MacFarlane, & Williamson, 1987). Subsequent studies have 
confirmed these findings (Samaranayake, 2009). The latter study was purely based on 
laboratory culture and species identification through phenotypic analyses. 
Imabayashi et al., (2016), using next generation sequencing of the ITS1 region, have 
examined the mycobiome in patients with candidal infections to explore the cohabiting 
fungal species They noted a relatively lower abundance of fungal species in patients with 
pseudomembranous oral candidiasis compared with healthy controls (Imabayashi et al., 
2016). There were 45 common fungal species between the test and the control subjects. 
However, only 22 additional fungal species were isolated exclusively from patients with 
pseudomembranous candidiasis compared to 41 additional fungal species identified 
exclusively from the healthy individuals. Significantly higher numbers of C. dubliniensis, C. 
parapsilosis, Wallumia sebi, Rhodosporidium babjevae, Candida krusei, Antrodiella micra, 
Cladosporium sphaerospermum, and Sporidiobolales species were noted in those with 
pseudomembranous candidiasis whereas healthy mouths were significantly colonized by 
Exophiala equina, Cladosporium halotolerans, and Agaricomycetes species (Imabayashi et 
al., 2016). Candida species were common to both the healthy and the candidiasis group 
although C. dubliniensis were more abundant with the latter group. The authors opined that 
there were no marked differences in the mycobiomes of the healthy and the candidiasis 
groups, and the pathogenesis of the disease is likely to be an outcome of the interplay of 
microbial strain shifts, pathogenic potential, and host immunity thus echoing the above 
sentiments of Shelburne et al., (Shelburne et al., 2015). 
 
Oral mycobiome and oral carcinoma 
Although oral cancer is a multifactorial disease, there are some reports indicating that 
Candida infected oral lesions have a higher propensity for malignant transformation 
(Gholizadeh et al., 2016; Sankari, Gayathri, Balachander, & Malathi, 2015). The conditions 
that have been investigated include oral squamous cell carcinoma (OSCC), lichen planus and 
fibro epithelial polyps. 
Recent NGS data tend to confirm this hypothesis as Perera et al., have noted a dysbiotic 
mycobiome with over representation by Candida, Hannaella, and Gibberella genera in OSCC. 
Alternaria and Trametes were more abundant in fibro epithelial polyps. Species-wise, C. 
albicans, Candida etchellsii, and a Hannaella luteola–like species were enriched in OSCC, 
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while a Hanseniaspora uvarum–like species, Malassezia restricta, and Aspergillus tamarii 
were the most significantly abundant in fibro epithelial polyps (Perera et al., 2017). 
Mechanisms that entail carcinogenesis in these conditions may include the production of 
carcinogenic compounds by Candida, such as nitrosamines and/or acetaldehyde (Gainza-
Cirauqui et al., 2013; Meurman & Uittamo, 2008). 
Conclusion and future directions 
On a cellular basis, approximately 0.1% of the microbes in the adult intestine are fungi, 
representing approximately 60 unique species (Hoffmann et al., 2013; Rajilic-Stojanovic & 
de Vos, 2014). Although equivalent data are not available for the oral mycobiome it is clear 
that the oral cavity offers a comfortable residence to a fair proportion of fungi. As fungi are 
difficult to grow in ordinary laboratory culture media, they have eluded detection and the 
predominant species belonging to the genus Candida have stolen the spotlight for decades, 
thus leaving the uncultivable fungi a hidden entity up until now.  
The arrival of NGS platforms has elucidated the hidden world of the oral mycobiome for the 
very first time, and a reasonable number of research articles are now available that is 
incrementally demystifying the oral mycobiome, as discussed above. Yet NGS technology 
platforms as well as the analysis of `big data` spewing out from such research are extremely 
cost intensive thus limiting the sample size in most evaluations to date. However, the recent 
advent of microfluidics technology, is a ray of hope. The latter technology (such as Fluidygm 
multiplex PCR) in combination with NGS permit the analysis of up to 40 samples in a single 
step with major efficiency and cost savings. 
There are a number of immediate and pressing questions that need addressed in the field of 
oral mycobiome. Broad surveys of the oral mycobiome have thus far captured snapshots of 
the dynamic fungal community but their chronologic evolution from infancy to adulthood 
through longitudinal studies are warranted. Longitudinal tracking of the early-life oral 
mycobiota using mother–infant pairs while monitoring health outcomes, such as allergies, 
and acute fungal infections such as pseudomembranous candidiasis seen in infancy should 
be of immense clinical interest.  
The inter-kingdom exploits of fungi-bacteria in the mouth is an area awaiting further 
studies, not only to better characterize their structural and functional relationships, but also 
their combined effects on disease initiation and progression. Other questions include the 
impact of the fungal community on the oral immune system, and whether they are 
accessory pathogens in oral diseases such as various periodontal diseases or indeed caries 
(Pereira, Seneviratne, Koga-Ito, & Samaranayake, 2018). Finally, research is necessary to 
address the methodological challenges in generating fungal microbiome data, so as to 
generate a comprehensive and a reliable reference database including sampling of the low 
fungal biomass extant in the oral ecosystem.   
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